 Nicholas Behrendt
Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 9 | 2022 | 227 | 1.740 |
Why?
| | Fetofetal Transfusion | 4 | 2022 | 23 | 1.450 |
Why?
| | Pregnancy, Twin | 3 | 2022 | 22 | 1.150 |
Why?
| | Premature Birth | 4 | 2023 | 284 | 0.770 |
Why?
| | Cervix Uteri | 3 | 2022 | 48 | 0.750 |
Why?
| | Fetal Development | 2 | 2021 | 250 | 0.670 |
Why?
| | Meningomyelocele | 4 | 2020 | 51 | 0.650 |
Why?
| | Pregnancy | 20 | 2023 | 5691 | 0.620 |
Why?
| | Lateral Ventricles | 1 | 2016 | 22 | 0.560 |
Why?
| | Cervical Ripening | 2 | 2013 | 7 | 0.560 |
Why?
| | Fetal Growth Retardation | 1 | 2021 | 468 | 0.560 |
Why?
| | Laser Coagulation | 1 | 2016 | 55 | 0.550 |
Why?
| | Hydrocephalus | 1 | 2016 | 81 | 0.530 |
Why?
| | Placenta | 3 | 2016 | 639 | 0.470 |
Why?
| | Pregnancy Complications | 3 | 2023 | 448 | 0.450 |
Why?
| | Uterine Hemorrhage | 1 | 2013 | 36 | 0.440 |
Why?
| | Fetus | 2 | 2023 | 690 | 0.410 |
Why?
| | Sex Determination Analysis | 1 | 2011 | 6 | 0.400 |
Why?
| | Gestational Age | 3 | 2022 | 765 | 0.400 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2023 | 189 | 0.370 |
Why?
| | Gastroschisis | 2 | 2020 | 18 | 0.360 |
Why?
| | Polycythemia | 2 | 2021 | 26 | 0.340 |
Why?
| | Fetal Therapies | 2 | 2019 | 32 | 0.330 |
Why?
| | Body Mass Index | 2 | 2019 | 2092 | 0.330 |
Why?
| | Twins, Monozygotic | 2 | 2021 | 214 | 0.310 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3174 | 0.280 |
Why?
| | Pregnancy Outcome | 3 | 2016 | 349 | 0.240 |
Why?
| | Bartter Syndrome | 1 | 2023 | 8 | 0.240 |
Why?
| | Polyhydramnios | 1 | 2023 | 18 | 0.240 |
Why?
| | Female | 22 | 2023 | 61565 | 0.240 |
Why?
| | Hernia, Umbilical | 1 | 2023 | 18 | 0.230 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 94 | 0.230 |
Why?
| | Urethral Obstruction | 1 | 2022 | 9 | 0.220 |
Why?
| | Amniotic Fluid | 1 | 2022 | 68 | 0.220 |
Why?
| | Urethral Diseases | 1 | 2022 | 19 | 0.210 |
Why?
| | Uterine Cervical Diseases | 1 | 2022 | 6 | 0.210 |
Why?
| | Urinary Tract | 1 | 2022 | 40 | 0.210 |
Why?
| | Fetoscopy | 2 | 2022 | 29 | 0.210 |
Why?
| | Pregnancy Reduction, Multifetal | 1 | 2021 | 7 | 0.200 |
Why?
| | Fetal Diseases | 1 | 2022 | 148 | 0.200 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 227 | 0.190 |
Why?
| | Twins, Dizygotic | 1 | 2021 | 182 | 0.190 |
Why?
| | Delivery, Obstetric | 1 | 2021 | 125 | 0.190 |
Why?
| | Fetal Death | 2 | 2023 | 52 | 0.190 |
Why?
| | Renal Insufficiency | 1 | 2022 | 150 | 0.180 |
Why?
| | Anemia | 1 | 2021 | 146 | 0.180 |
Why?
| | Obstetric Surgical Procedures | 1 | 2019 | 5 | 0.180 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2022 | 240 | 0.170 |
Why?
| | Maternal Health | 1 | 2019 | 45 | 0.170 |
Why?
| | Tocolytic Agents | 1 | 2018 | 16 | 0.170 |
Why?
| | Indomethacin | 1 | 2018 | 75 | 0.160 |
Why?
| | Humans | 22 | 2023 | 118974 | 0.160 |
Why?
| | Ductus Arteriosus | 1 | 2018 | 67 | 0.160 |
Why?
| | Maternal Exposure | 1 | 2020 | 142 | 0.160 |
Why?
| | Hysterotomy | 1 | 2017 | 10 | 0.160 |
Why?
| | Muscle Proteins | 2 | 2009 | 219 | 0.150 |
Why?
| | Prenatal Care | 2 | 2017 | 252 | 0.150 |
Why?
| | Retrospective Studies | 8 | 2023 | 12978 | 0.140 |
Why?
| | Comorbidity | 1 | 2021 | 1527 | 0.140 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 304 | 0.130 |
Why?
| | Kidney | 1 | 2022 | 1353 | 0.130 |
Why?
| | Pregnancy, Multiple | 1 | 2014 | 19 | 0.130 |
Why?
| | Opioid-Related Disorders | 1 | 2020 | 417 | 0.120 |
Why?
| | Twins | 1 | 2014 | 247 | 0.110 |
Why?
| | Abnormalities, Multiple | 1 | 2014 | 181 | 0.110 |
Why?
| | Risk Factors | 3 | 2021 | 9000 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2009 | 1055 | 0.110 |
Why?
| | Prospective Studies | 3 | 2013 | 6471 | 0.100 |
Why?
| | Organ Size | 1 | 2013 | 460 | 0.100 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2011 | 38 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1794 | 0.100 |
Why?
| | Pregnancy Trimester, First | 1 | 2011 | 126 | 0.090 |
Why?
| | Trophoblasts | 2 | 2009 | 170 | 0.090 |
Why?
| | Predictive Value of Tests | 2 | 2011 | 1868 | 0.090 |
Why?
| | Young Adult | 5 | 2020 | 10793 | 0.080 |
Why?
| | Infant, Newborn | 4 | 2023 | 5255 | 0.080 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 703 | 0.080 |
Why?
| | Pre-Eclampsia | 1 | 2009 | 183 | 0.070 |
Why?
| | Obesity | 1 | 2019 | 2746 | 0.070 |
Why?
| | Adult | 6 | 2020 | 31512 | 0.070 |
Why?
| | Infant | 3 | 2023 | 8293 | 0.060 |
Why?
| | Lung Volume Measurements | 1 | 2023 | 46 | 0.060 |
Why?
| | Morbidity | 1 | 2023 | 296 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 228 | 0.050 |
Why?
| | Cerclage, Cervical | 1 | 2022 | 5 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 394 | 0.050 |
Why?
| | Bupivacaine | 1 | 2020 | 34 | 0.050 |
Why?
| | Anesthetics, Local | 1 | 2020 | 85 | 0.050 |
Why?
| | Lung | 2 | 2023 | 3664 | 0.050 |
Why?
| | Maternal Age | 1 | 2020 | 122 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4196 | 0.040 |
Why?
| | Dysferlin | 2 | 2009 | 6 | 0.040 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2019 | 33 | 0.040 |
Why?
| | Perinatal Death | 1 | 2019 | 23 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2020 | 211 | 0.040 |
Why?
| | Constriction | 1 | 2018 | 46 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 85 | 0.040 |
Why?
| | Tissue Distribution | 2 | 2009 | 334 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3171 | 0.040 |
Why?
| | Enteral Nutrition | 1 | 2019 | 170 | 0.040 |
Why?
| | Survival Rate | 1 | 2022 | 1720 | 0.040 |
Why?
| | Calcium-Binding Proteins | 2 | 2009 | 217 | 0.040 |
Why?
| | Time Factors | 2 | 2019 | 6412 | 0.030 |
Why?
| | Health Status | 1 | 2019 | 726 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1945 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 794 | 0.030 |
Why?
| | Registries | 1 | 2020 | 1810 | 0.030 |
Why?
| | Term Birth | 1 | 2011 | 17 | 0.030 |
Why?
| | Uterine Contraction | 1 | 2011 | 16 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2011 | 70 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3057 | 0.020 |
Why?
| | Reference Values | 1 | 2011 | 774 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2009 | 29 | 0.020 |
Why?
| | Colforsin | 1 | 2009 | 55 | 0.020 |
Why?
| | Cell Fusion | 1 | 2009 | 51 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2011 | 272 | 0.020 |
Why?
| | Adolescent | 2 | 2022 | 18480 | 0.020 |
Why?
| | Cell-Derived Microparticles | 1 | 2009 | 62 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4596 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2019 | 2235 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1293 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 412 | 0.020 |
Why?
| | Down-Regulation | 1 | 2009 | 627 | 0.020 |
Why?
| | Cell Membrane | 1 | 2009 | 710 | 0.020 |
Why?
| | Male | 1 | 2011 | 57801 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9342 | 0.020 |
Why?
| | Phenotype | 1 | 2011 | 3003 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2657 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1715 | 0.010 |
Why?
| | Cohort Studies | 1 | 2011 | 5116 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4077 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2009 | 2445 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 4552 | 0.010 |
Why?
| | Middle Aged | 1 | 2009 | 27617 | 0.010 |
Why?
|
|
Behrendt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|